Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review. - Suppr | 超能文献

Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review.

作者信息

Gustavsson B, Hafström L

出版信息

Acta Chir Scand Suppl. 1981;504:1-28.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review.

Acta Chir Scand Suppl. 1981;504:1-28.

2

Metastatic colorectal carcinoma. Response to hepatic infusion. A review.

Mo Med. 1970 Mar;67(3):163-8.

3

[Treatment with cytostatic agents should be considered in colorectal cancer. It improves prognosis and quality of life].

Lakartidningen. 1999 May 12;96(19):2314-6.

4

[Palliative treatment with cytostatics of metastatic colorectal cancer in general practice. A model].[基层医疗中转移性结直肠癌的细胞毒性药物姑息治疗。一个模型]

Tidsskr Nor Laegeforen. 1997 Nov 10;117(27):3969-72.

5

Adjuvant therapy of colorectal cancer.结直肠癌的辅助治疗

Surg Oncol Clin N Am. 1997 Oct;6(4):699-722.

6

[Impact of perioperative chemotherapy on prognosis of colorectal cancer: a report of 82 cases].[围手术期化疗对结直肠癌预后的影响：82例报告]

Ai Zheng. 2007 Dec;26(12):1350-3.

7

[Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases].[结直肠癌肝转移手术治疗的疗效——附198例报告]

Ai Zheng. 2006 May;25(5):596-8.

8

[Therapeutic strategies in colorectal cancer].[结直肠癌的治疗策略]

Dtsch Med Wochenschr. 2003 Sep 12;128(37):1902-7. doi: 10.1055/s-2003-42159.

9

Adjuvant chemotherapy of colorectal carcinoma.结直肠癌的辅助化疗。

Ariz Med. 1982 Aug;39(8):524-5.

10

[Palliative chemotherapy in colorectal cancer: new molecular drugs].[结直肠癌的姑息化疗：新型分子药物]

Ann Gastroenterol Hepatol (Paris). 1995 Mar-Apr;31(2):106-8.

引用本文的文献

1

Incorporation of pyrimidines and 5-fluoropyrimidines into normal tissues and an adenocarcinoma transplanted into the liver in rat.嘧啶和5-氟嘧啶在大鼠正常组织及移植到肝脏的腺癌中的掺入情况。

J Cancer Res Clin Oncol. 1985;110(2):95-7. doi: 10.1007/BF00402718.

2

Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients.

Eur J Clin Pharmacol. 1987;32(4):411-8. doi: 10.1007/BF00543978.

3

Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Cancer Chemother Pharmacol. 1990;26(3):205-9. doi: 10.1007/BF02897200.

4

Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through system.使用流通系统测定5-氟尿嘧啶在人源和大鼠癌细胞系以及大鼠肝细胞中的体外细胞药代动力学。

Cancer Chemother Pharmacol. 1991;27(4):320-5. doi: 10.1007/BF00685119.